Source:http://linkedlifedata.com/resource/pubmed/id/19095572
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-12-19
|
pubmed:abstractText |
Our aim was to evaluate the usefulness of the monoclonal antibody Das-1 as a premalignant marker of gastric intestinal metaplasia (GIM) associated with gastric cancer and its association with mucin expression. We evaluated Das-1 and mucin expression in 4 groups: 1 (n = 50), gastric carcinoma, paired samples of the cancer area and GIM away from the tumor; 2 (n = 25), gastric or duodenal ulcer with Helicobacter pylori infection with GIM and chronic gastritis; 3 (n = 25),H pylori- autoimmune chronic atrophic gastritis with GIM; and 4 (n = 25),H pylori- chronic gastritis without GIM. Das-1 immunostaining was observed in 20 (40%) of 50 cases in cancer areas. The expression of Das-1 in GIM from group 1 cases away from the cancer area was different from that in GIM from nontumor cases (groups 2 and 3): 13 (26%) of 50 vs 2 (8%) and 0 (0%) of 25 (P = .004). There was no association between Das-1 and mucin expression. Das-1 expression was associated with GIM from patients with gastric cancer. However, this relation was weaker than previously reported, precluding clinical usefulness as a premalignant marker of GIM.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1943-7722
|
pubmed:author |
pubmed-author:CasalotsJaumeJ,
pubmed-author:EspinósJorgeJ,
pubmed-author:EsteveMariaM,
pubmed-author:Fernández-BañaresFernandoF,
pubmed-author:FornéMontserratM,
pubmed-author:Garcia-GilL JesúsLJ,
pubmed-author:González-MínguezClarisaC,
pubmed-author:LorasCarmeC,
pubmed-author:Poblet-MasNúriaN,
pubmed-author:RosinachMercèM,
pubmed-author:SalasAntonioA,
pubmed-author:ViverJosep MJM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
131
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
99-105
|
pubmed:dateRevised |
2010-5-17
|
pubmed:meshHeading |
pubmed-meshheading:19095572-Adult,
pubmed-meshheading:19095572-Aged,
pubmed-meshheading:19095572-Antibodies,
pubmed-meshheading:19095572-Antibodies, Monoclonal,
pubmed-meshheading:19095572-Gastritis,
pubmed-meshheading:19095572-Helicobacter pylori,
pubmed-meshheading:19095572-Humans,
pubmed-meshheading:19095572-Metaplasia,
pubmed-meshheading:19095572-Middle Aged,
pubmed-meshheading:19095572-Mucins,
pubmed-meshheading:19095572-Risk,
pubmed-meshheading:19095572-Stomach,
pubmed-meshheading:19095572-Stomach Neoplasms,
pubmed-meshheading:19095572-Stomach Ulcer
|
pubmed:year |
2009
|
pubmed:articleTitle |
Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia.
|
pubmed:affiliation |
Department of Gastroenterology, Hospital Universitari Mútua Terrassa, Terrassa, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|